Key statistics
On Wednesday, BioNexus Gene Lab Corp (BGLC:NAQ) closed at 0.41, 32.26% above the 52 week low of 0.31 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4162 |
---|---|
High | 0.425 |
Low | 0.40 |
Bid | 0.41 |
Offer | 0.425 |
Previous close | 0.425 |
Average volume | 76.38k |
---|---|
Shares outstanding | 17.97m |
Free float | 10.11m |
P/E (TTM) | -- |
Market cap | 7.64m USD |
EPS (TTM) | -0.1108 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 19:30 BST.
More ▼
Announcements
- BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
- BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
- BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
- BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
More ▼